"リゲル" の関連情報検索結果

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Ya...



Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)  Yahoo Finance

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update - PR Newswire



Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update  PR Newswire

2024 October 31 - Rigel and the Witch Head Nebula - Astronomy Picture of the Day



2024 October 31 - Rigel and the Witch Head Nebula  Astronomy Picture of the Day

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for...



Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®  GlobeNewswire

Rigel Pharma CFO to Present at Jefferies London Healthcare Conference - StockTitan



Rigel Pharma CFO to Present at Jefferies London Healthcare Conference  StockTitan

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial - Clinical Trials Arena



Rigel enrols first participant in Phase Ib/II AML treatment regimen trial  Clinical Trials Arena

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meetin...



Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition  PR Newswire

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance



Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations  Yahoo Finance

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) - PR News...



Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)  PR Newswire

Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates - Yahoo Finance



Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates  Yahoo Finance

Rigel to Present at the 2024 Cantor Global Healthcare Conference - PR Newswire



Rigel to Present at the 2024 Cantor Global Healthcare Conference  PR Newswire

Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Intera...



Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive  Yahoo Finance

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republi...



Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan  PR Newswire

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... - ...



Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...  Yahoo Finance

Rigel to Present at the Jefferies London Healthcare Conference - PR Newswire



Rigel to Present at the Jefferies London Healthcare Conference  PR Newswire

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update - PR Newswire



Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update  PR Newswire

Rigel Announces Reverse Stock Split - PR Newswire



Rigel Announces Reverse Stock Split  PR Newswire

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasi...



Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML  PR Newswire

Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application - PR News...



Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application  PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Bu...



Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update  Yahoo Finance

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS - Yahoo Finance



Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS  Yahoo Finance

Rigel Announces Reverse Stock Split | RIGL Stock News - StockTitan



Rigel Announces Reverse Stock Split | RIGL Stock News  StockTitan

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th A...



Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition  Yahoo Finance

With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional in...



With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance



Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect  Yahoo Finance

Rigel Pharmaceuticals: Looking For More Growth (NASDAQ:RIGL) - Seeking Alpha



Rigel Pharmaceuticals: Looking For More Growth (NASDAQ:RIGL)  Seeking Alpha

Travelmarvel's 2026 Europe features new river vessel, Rigel - Seatrade Cruise News



Travelmarvel's 2026 Europe features new river vessel, Rigel  Seatrade Cruise News

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St



Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations  Simply Wall St

Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships - Seeki...



Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships  Seeking Alpha

Optime Care Announces Enhanced Partnership with Rigel Pharmaceuticals for GAVRETO® Patients - Bus...



Optime Care Announces Enhanced Partnership with Rigel Pharmaceuticals for GAVRETO® Patients  Business Wire

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with...



Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma  PR Newswire

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® - PR Newswire



Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®  PR Newswire

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic? - Yahoo Finance



Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?  Yahoo Finance

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 36% Below Their Intrinsic Value Estimat...



Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 36% Below Their Intrinsic Value Estimate  Simply Wall St

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer - PR ...



Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer  PR Newswire

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - ...



Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update  PR Newswire

Rigel Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks



Rigel Pharmaceuticals Reports Strong Q3 2024 Results  TipRanks

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript - Insider Monkey



Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript  Insider Monkey

Rigel Cabinetry launches digital catalog - LBM Journal



Rigel Cabinetry launches digital catalog  LBM Journal

Meet Dr. Rigel Pinon-sloss - Bold Journey Magazine



Meet Dr. Rigel Pinon-sloss  Bold Journey Magazine

Rigel Resource Faces NYSE Delisting, Plans NASDAQ Listing - TipRanks



Rigel Resource Faces NYSE Delisting, Plans NASDAQ Listing  TipRanks

Witch Head Nebula is perfect on October nights - EarthSky



Witch Head Nebula is perfect on October nights  EarthSky

Jackie Rigel-Burkholder Obituary (1961 - 2024) - Lima, OH - The Lima News - Legacy.com



Jackie Rigel-Burkholder Obituary (1961 - 2024) - Lima, OH - The Lima News  Legacy.com

Moon Rigel Max light review - BikeRadar



Moon Rigel Max light review  BikeRadar

US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets - BSA ...



US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets  BSA bureau

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel - FiercePharma



After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel  FiercePharma

CD Review | Rigel : Le souffle de la Révolution — Arion Baroque Orchestra - La Scena Musicale



CD Review | Rigel : Le souffle de la Révolution — Arion Baroque Orchestra  La Scena Musicale

Laura Rigel Obituary (2024) - Leipsic, OH - The Lima News - Legacy.com



Laura Rigel Obituary (2024) - Leipsic, OH - The Lima News  Legacy.com

Blueprint’s Cancer Drug Gavreto Finds New Home at Rigel after Roche Split - BioSpace



Blueprint’s Cancer Drug Gavreto Finds New Home at Rigel after Roche Split  BioSpace

India: Rigel Capital leads $25m funding in adtech startup AdOnMo - DealStreetAsia



India: Rigel Capital leads $25m funding in adtech startup AdOnMo  DealStreetAsia

Meet Rigel Yaluk Mosquera - Bold Journey Magazine



Meet Rigel Yaluk Mosquera  Bold Journey Magazine

Rigel In ‘The Tearsmith’ Explained: Why Did Rigel Choose Not To Be Adopted? - imdb



Rigel In ‘The Tearsmith’ Explained: Why Did Rigel Choose Not To Be Adopted?  imdb

Gold Miner Aurous Combining with Rigel Resource Acquisition in $362M Deal - DealFlow's SPAC News



Gold Miner Aurous Combining with Rigel Resource Acquisition in $362M Deal  DealFlow's SPAC News

2024, April 25: Rigel Slips into Bright Evening Twilight - When the Curves Line Up



2024, April 25: Rigel Slips into Bright Evening Twilight  When the Curves Line Up

Sembmarine disposes of West Rigel for $500m - Seatrade Maritime News



Sembmarine disposes of West Rigel for $500m  Seatrade Maritime News

Rigel Name Meaning, Origin, History, And Popularity - MomJunction



Rigel Name Meaning, Origin, History, And Popularity  MomJunction

Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year - Ya...



Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year  Yahoo Finance

Aurous to merge with Rigel for NASDAQ listing - Mining Technology



Aurous to merge with Rigel for NASDAQ listing  Mining Technology

After Roche’s exit, Blueprint passes Gavreto on to Rigel - pharmaphorum



After Roche’s exit, Blueprint passes Gavreto on to Rigel  pharmaphorum

Rigel’s new skin-penetrant IRAK-1/4 inhibitor shows promise for psoriasis - BioWorld Online



Rigel’s new skin-penetrant IRAK-1/4 inhibitor shows promise for psoriasis  BioWorld Online

The Tearsmith Ending, Explained: What Happened to Rigel? - MovieWeb



The Tearsmith Ending, Explained: What Happened to Rigel?  MovieWeb

Rigel Fails to Redefine 'Water' in Mixed Ruling on Drug Patents - Bloomberg Law



Rigel Fails to Redefine 'Water' in Mixed Ruling on Drug Patents  Bloomberg Law

Rigel takes on US marketing of Blueprint’s Gavreto - BioWorld Online



Rigel takes on US marketing of Blueprint’s Gavreto  BioWorld Online

Delving into the emotional ending of Netflix's The Tearsmith - Digital Spy



Delving into the emotional ending of Netflix's The Tearsmith  Digital Spy

The Tearsmith Ending, Explained: What Happened to Rigel? - MSN



The Tearsmith Ending, Explained: What Happened to Rigel?  MSN

The Tearsmith ending explained: Do Nica and Rigel end up together? - Sportskeeda



The Tearsmith ending explained: Do Nica and Rigel end up together?  Sportskeeda

MD Anderson and Rigel collaborate to advance olutasidenib in AML - MD Anderson Cancer Center



MD Anderson and Rigel collaborate to advance olutasidenib in AML  MD Anderson Cancer Center

Rigel Pharmaceuticals Provides Business Update - PR Newswire



Rigel Pharmaceuticals Provides Business Update  PR Newswire

Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma -...



Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma  PR Newswire

Blue-white Rigel is Orion’s brightest star - EarthSky



Blue-white Rigel is Orion’s brightest star  EarthSky

Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult ...



Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation  PR Newswire

Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalki...



Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalking and threats'  Berkeleyside

ImmunityBio Backslides while Rigel and Amneal also Reveal Job Cuts (Updated) - BioSpace



ImmunityBio Backslides while Rigel and Amneal also Reveal Job Cuts (Updated)  BioSpace

Help from Orion - Science@NASA



Help from Orion  Science@NASA

Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treat...



Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases  Investors | Eli Lilly and Company

2022 January 24 - Rigel and the Witch Head Nebula - Astronomy Picture of the Day



2022 January 24 - Rigel and the Witch Head Nebula  Astronomy Picture of the Day

OSP says Selma warrant detectives found Jesse Rigel, drugs and guns - KDRV



OSP says Selma warrant detectives found Jesse Rigel, drugs and guns  KDRV

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA - Fierce Biotech



Rigel bets $230M that Forma's leukemia drug gets in formation with FDA  Fierce Biotech

Berkeley City Councilmember Rigel Robinson resigns, citing harassment, burnout - East Bay Times



Berkeley City Councilmember Rigel Robinson resigns, citing harassment, burnout  East Bay Times

Rigel scores green light in AML just 4 months after buying asset from Forma - FiercePharma



Rigel scores green light in AML just 4 months after buying asset from Forma  FiercePharma

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., ...



Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ (fostamatinib disodium hexahydrate) in Japan and other Asian Countries  PR Newswire

Cynthia Rigel Obituary | Mar 24, 2023 | Bowling Green, OH - Deck-Hanneman Funeral Home



Cynthia Rigel Obituary | Mar 24, 2023 | Bowling Green, OH  Deck-Hanneman Funeral Home

Bad News for Berkeley Advocates: Rigel Robinson Resigns from City Council - Streetsblog San Franc...



Bad News for Berkeley Advocates: Rigel Robinson Resigns from City Council  Streetsblog San Francisco

Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors - Fierce Biotech



Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors  Fierce Biotech

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercial...



Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe  PR Newswire

Gemini Forges Rigel Carbon MTB Chainrings, the World’s Lightest at 39g Make You Faster! - BikeRum...



Gemini Forges Rigel Carbon MTB Chainrings, the World’s Lightest at 39g Make You Faster!  BikeRumor.com

Meet Rigel, Orion's Blue Suede Shoe - Sky & Telescope



Meet Rigel, Orion's Blue Suede Shoe  Sky & Telescope

Renowned Dermatologist Darrell S. Rigel, MD, MS, Joins Cooper Clinic Practice - GlobeNewswire



Renowned Dermatologist Darrell S. Rigel, MD, MS, Joins Cooper Clinic Practice  GlobeNewswire

A guide to star Rigel - Sky at Night Magazine



A guide to star Rigel  Sky at Night Magazine

Rigel: Orion's Brightest Star - Space.com



Rigel: Orion's Brightest Star  Space.com

RRAC.U IPO News - Mining-focused SPAC Rigel Resource Acquisition files for a $250 million IPO - R...



RRAC.U IPO News - Mining-focused SPAC Rigel Resource Acquisition files for a $250 million IPO  Renaissance Capital

Becky Rigel - Sports Illustrated



Becky Rigel  Sports Illustrated

Looking Up: Rigel marks Orion’s ‘left foot’ - The Columbus Dispatch



Looking Up: Rigel marks Orion’s ‘left foot’  The Columbus Dispatch

FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data...



FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data  FiercePharma

Election 2018: Who is Rigel Robinson? - Berkeleyside



Election 2018: Who is Rigel Robinson?  Berkeleyside

Rigel Stuhmiller: From soccer sidelines to bird prints - Berkeleyside



Rigel Stuhmiller: From soccer sidelines to bird prints  Berkeleyside

The Ongoing Struggle for the City: A Conversation with Rigel Sergent - Venezuelanalysis.com



The Ongoing Struggle for the City: A Conversation with Rigel Sergent  Venezuelanalysis.com